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many possible cis-acting elements and the high CpG content
underscore the potential signi®cance of this region for gene
regulation, and the importance of a precise understanding of the
gene in this region.
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Isolated Hemoperfused Porcine Skin as a Valid Model to
Assess Percutaneous Absorption1
To the Editor:
The passage of topically administered dermatologic drugs across the
human skin and consecutive systemic adverse reactions can
signi®cantly limit the use of topical drugs and represents one of
the main problems in the development of new topical compounds
(Zucchi et al, 2001). Also, transdermal absorption is a major
pathway for environmental toxins or allergens to reach the systemic
circulation, and how drugs such as analgesics may be administered
systemically (Levy, 1996). The passage through cutaneous mem-
branes chie¯y occurs according to the laws of passive diffusion or
carrier-mediated transport mechanisms and the extent of absorption
of drugs and toxins is thus largely determined by their
physicochemical properties (Hadgraft and Pugh, 1998). Until
now, most studies on skin permeation have been carried out using
living laboratory animals (Brown et al, 1999) or humans (Leopold
and Maibach, 1999) and, therefore, dermatologic drug develop-
ment is partly the focus of ethical controversy.
In this study, a model of isolated perfused porcine skin was
developed to assess transdermal absorption using porcine forelegs
(average organ weight 1514.5 6 101 g) of eight female pigs. The
organs were harvested after desanguination for the collection of
autologous blood from commercial abattoir pigs to reduce animal
experiments as previously suggested for perfusion studies of the pig
ear (VanRooij et al, 1995). After transfer to the laboratory using
cold preservation, the organs were placed in a perfusion system and
normothermic pressure controlled perfusion was performed
through the brachial artery with a pressure of 100 mmHg and
perfusates were periodically collected for analysis. The perfusion
system consisted of a blood and a dialysis circuit (Fig 1A) The
dialysate (composition in mmol per liter: 142.5 Na+, 2.9 K+, 1.5
Ca2+, 0.5 Mg2+, 109.9 Cl±, 37 HCO3
±, 2.5 CH3COO
±, 3.55
glucose) reservoir with a capacity of 10 l was permanently enriched
Figure 2. Potential cis-acting regulatory
regions in phylogenetically conserved regions
of the mouse and human plakoglobin genes.
This ``regulogram'' (Jegga et al, in press) shows a
comparison of the mouse (top) and human
(bottom) plakoglobin gene sequences aligned by
BlastZ (Schwartz et al, 2000). Exons are shown as
dark boxes. Homologous conserved regions are
connected by shaded polygons. Potential cis-
elements were identi®ed using MatInspector
(Werner, 2000) and the TRANSFAC professional
transcription factor binding site database. Cis-
elements contained within a 200 bp window of
the homologous regions are scored as a hit. Hits
per 200 bp window are shown on the Y-axis.
Further detailed analyses of implicated cis-elements
can be viewed at: http//trafac.chmcc.org/
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with 97.5% O2 and 2.5% CO2 and adjusted to 38°C by a heat
exchanger. The model drug for testing transdermal absorption was
fentanyl, which was applied using a transdermal fentanyl system
(transdermal therapeutic system, 50 mg per h; Durogesic, Janssen-
Cilag, Neuss, Germany). This compound was chosen because of its
widespread clinical use (Allan et al, 2001) and the existence of a
transdermal application system that ensures a continuos percuta-
neous administration (Grond et al, 2000). The transdermal thera-
peutic system patch was placed radially on the foreleg and fentanyl
levels were examined using commercial radioimmunoassay and gas
chromatography tests (Coat-Account, DPC, Los Angeles, CA).
Besides the assessment of functional parameters for organ viability,
oxygen consumption, serum electrolytes [sodium (mmol per liter),
potassium (mmHg), chloride (mmol per liter), calcium (mmol per
liter)], glucose (mg per dl), lactate (mg per dl), pO2 (mmHg), and
pCO2 (mmHg) were examined.
The perfusion experiments were carried out over a period of
7 h. The sodium and chloride concentrations remained constant
during the perfusion period of 420 min ranging from
145.4 6 2.1 to 150.7 6 1.9 mmol per liter and 105.3 6 2.1
to 106.1 6 2.1 mmol per liter, respectively, whereas there was
an increase of potassium and calcium from initially
4.69 6 0.40 mmol per liter at 60 min to 5.65 6 0.48 mmol
per liter after 420 min and 0.47 6 0.10 mmol per liter to
0.60 6 0.11 mmol per liter, respectively. In all experiments,
percutaneous fentanyl absorption was detectable with increasing
plasma levels from 28.5 6 16.5 pg at 60 min to
602.3 6 295.1 pg at 240 min and 1774.3 6 453.3 pg at
420 min (Fig 1B). The analysis of hemodynamic parameters
demonstrated constant perfusion ¯ows ranging from 4.97 6
0.25 ml per min per 100 mg at 60 min to 4.96 6 0.25 ml per
min per 100 mg at 240 min. Also, the arterial pressure
remained constant within limits of 80.6 6 8.8 mmHg
(240 min) to 87.8 6 9.4 mmHg (420 min). Organ resistance
values were found at levels of 17.3 6 1.8 mmHg 3 min per
100 g per ml (60 min) to 18.3 6 2.3 mmHg 3 min per 100 g
per ml (420 min). Whereas the arterial and venous protein
parameters remained constant during the perfusions
(1.77 6 0.12 g arterial albumin per dl, 1.77 6 0.10 g venous
albumin per dl at 420 min) metabolic parameters changed;
lactate levels increased from 40.1 6 5.1 mg per dl (arterial) and
47.7 6 4.1 mg per dl (venous) at 60 min to 85.0 6 7.2 mg per
dl (arterial) and 91.6 6 7.1 mg per dl (venous) at 420 min. Also
glucose levels decreased from 123.3 6 21.7 mg per dl (arterial)
and 115.7 6 21.6 mg per dl (venous) at 60 min to
62.1 6 13.7 mg per dl (arterial) and 55.9 6 11.2 mg per dl
(venous) at 420 min. The arteriovenous glucose consumption
exhibited a peak at 180 min (Fig 1D), whereas the oxygen
consumption resembling the main criteria of organ viability
(Adham et al, 1997), decreased slightly from 0.097 6 0.013 ml
per min per 100 g at 60 min to 0.079 6 0.012 ml per min per
100 g at 420 min (Fig 1C), but stayed within physiologic
ranges. Enzyme analysis revealed constant increases for lactic
dehydrogenase from 2162 6 78 U per liter (arterial) and
Figure 1. Assessment of percutaneous drug
absorption using a model of isolated
hemoperfused porcine skin and fentanyl as
the model drug. (A) A perfusion set-up
consisting of a blood and dialysis circuit was
applied to establish a model of isolated
hemoperfused perfused porcine skin (A, arterial
sample, V, venous sample, Q, ¯owmeter, T, air
trap, P, pressure transducer, é, pump). (B)
Fentanyl plasma levels measured in the model
after 60, 180, 300, and 420 min. (C) The oxygen
consumption expressed as ml per min per 100 g
revealed constant values and (D) also glucose
consumption values stayed within physiologic
ranges. Histology before (E) and after 6 h of
perfusion (F). Scale bars: 100 mm.
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2347 6 289 U per liter (venous) at 60 min to 6171 6 1871 U
per liter (arterial) and 6028 6 916 U per liter (venous) at
420 min.
The organ-speci®c data with hemodynamic and hematologic
parameters of arterial pressure and ¯ow, organ resistance,
hematocrit, albumin, oxygen saturation and consumption, sodium,
potassium, lactic dehydrogenase, and glucose consumption illustrate
the proximity of this model to established models of isolated
perfused organs, such as liver or kidney, which are used for
transplantation research (Schon et al, 1993; Zarzuelo et al, 2000).
Also, intact skin morphology was revealed (Fig 1E,F) using
previously described histology protocols (Fischer et al, 2001;
Groneberg et al, 2001).
In summary, the present model of isolated normothermic
hemoperfused skin using porcine forelegs allows a continuous
assessment of drug or environmental compound absorption
within a period of up to 7 h. As shown previously, there is a
large variability in the pharmacokinetics of fentanyl absorption
(Plezia et al, 1989) despite the rate control membrane that
reduces the variation in skin drug transport by 50% (Hwang et
al, 1991).
The skin of small laboratory animals possess signi®cant differ-
ences in organ function and morphology in comparison with
human skin. Therefore, the isolated porcine skin model may be a
useful approach to simulate human conditions with an isolated
system consisting of the skin and the adjacent musculo-veno-
arterial area; however, although porcine skin reacts qualitatively
similar to human skin, there may be quantitative differences in the
permeability to drugs in the presence of fatty alcohols (Andega et al,
2001). The system seems to be a well-balanced model to investigate
percutaneous absorption of drugs as it shares similarities in drug
absorption and plasma levels if compared with human conditions of
transdermal drug application as shown here for fentanyl (Plezia et al,
1989). The ex vivo perfused porcine skin may also be a more
suitable model for testing the topical administration of drugs as it is
by far more similar to physiologic conditions as compared with
in vitro cell culture tests. Future studies on the percutaneous
absorption of newly developed compounds in the present model
could also include the measurement of transepidermal water loss as
a marker of permeability barrier function. As the organs and
autologous blood can be obtained from commercial abattoirs in
high numbers, and the model does not con¯ict with animal welfare
acts, experimental animal numbers can be reduced and thus ethical
concerns about dermatologic or cosmetic drug testing may be
diminished.
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